Dr. Ian Davis is a physician-scientist in pediatric hematology and oncology with expertise in sarcoma and solid tumors. He is the G. Denman Hammond Professor of Childhood Cancer and Chief of the Division of the Pediatric Hematology-Oncology.
Education and Training
BA, Northwestern University
MD, Northwestern University Medical School
PhD, University of Illinois at Chicago
Internship and Residency in Medicine, Children’s Hospital, Boston
Fellowship, Clinical, Children’s Hospital, Boston / Dana-Farber Cancer Institute, Pediatric Hematology/Oncology
Fellowship, Research, Children’s Hospital, Boston / Dana-Farber Cancer Institute, Cancer Biology
Research
Dr. Davis’ research uses cell and animal models and a combination of genomic and proteomic approaches to study the connection between gene regulation and the development of cancer. With a focus on pediatric solid tumors, such as Ewing sarcoma, his lab has worked to develop new therapies and diagnostics through their studies of chromatin organization and gene transcription in cancer progression. His lab has been specifically focused on the role of the critical oncogene in Ewing sarcoma to alter the way that proteins and DNA are associated in the nucleus of tumor cells. The lab is also exploring whether targeted therapies can improve cellular immunotherapy for pediatric cancers.
